64
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer

, , , , &
Pages 1969-1975 | Published online: 11 Mar 2015

Figures & data

Table 1 Patient characteristics

Table 2 Clinical and pathological responses

Figure 1 Comparison of the efficacy of nab-paclitaxel and paclitaxel in subgroup analysis.

Abbreviations: BMI, body mass index; CI, confidence interval; ER, estrogen receptor; HR, hazard ratio; PR, progesterone receptor; HER2, human epidermal receptor-2; cT, clinical tumor stage; cN, clinical lymph nodal stage.

Figure 1 Comparison of the efficacy of nab-paclitaxel and paclitaxel in subgroup analysis.Abbreviations: BMI, body mass index; CI, confidence interval; ER, estrogen receptor; HR, hazard ratio; PR, progesterone receptor; HER2, human epidermal receptor-2; cT, clinical tumor stage; cN, clinical lymph nodal stage.

Table 3 Common treatment-related grade 1–4 adverse events